Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Drais Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Telsar Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01612039
First received: June 1, 2012
Last updated: April 1, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)